Intelligene Inc. (TPEX:7832)

Market Cap	8.21B
Revenue (ttm)	3.36M +53.5%
Net Income	-166.81M
EPS	-0.32
Shares Out	580.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	484,249
Average Volume	445,284
Open	13.80
Previous Close	14.05
Day's Range	13.50 - 14.40
52-Week Range	4.73 - 17.65
Beta	n/a
RSI	54.85
Earnings Date	Apr 10, 2026

About Intelligene

Intelligene Inc. engages in the research and development of RNA gene therapy drugs in Taiwan and Australia. The company offers IG-001, a siRNA-based drug which is under preclinical trials for the treatment of coronavirus disease; and IG-002, a siRNA-based drug which is under drug screening for the treatment of influenza. It also provides lipid nanoparticle and exosome drug encapsulation technologies to customize drug carriers and develop nucleic acid therapeutics. The company was founded in 2023 and is based in Taipei, Taiwan.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2023
• Employees: 20
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7832